JawBuddy raises €818k pre-Seed for jaw pain app trial

Leipzig-based JawBuddy has raised €818k in a pre-Seed round led by the healthcare platform HALBZEIT, EU-Startups reports. eu-startups.com The company develops an app that helps people reduce jaw pain, bruxism and TMJ-related tension. eu-startups.com It plans to use the capital to fund its own efficacy study and to work towards reimbursement by health insurers. eu-startups.com

The round was also backed by Dr. Siegfried Marquardt, a specialist in aesthetic and functional dentistry and implantology, and by oral and maxillofacial surgeon Dr. Guido Sigron. Mittelständische Beteiligungsgesellschaft Sachsen (MBG) and business angels Christophe Barriolade, Aldrich Huang, Jens Kosche and Marc Scheidegger also took part. The total includes the Business Angel Bonus from Sächsische Aufbaubank. eu-startups.com

How the app works

JawBuddy was founded in 2025 by Leon Rauch, Moritz Scherer and Benjamín Cádiz de Gracia and is based at SpinLab in Leipzig. eu-startups.com The company states that the app guides patients through a personalised self-therapy programme at home and measures progress with the smartphone camera. It also supports people with bruxism, the unconscious grinding or clenching of teeth. eu-startups.com

According to the company, all exercises are evidence-based. They were created by Scherer, a physiotherapist, M.Sc. and PhD candidate in Health Technologies, and by Dr. Christian Wolf, a practising oral and maxillofacial surgeon at Kantonsspital Aarau. JawBuddy says it adapts the exercise plan using users' assessments, daily feedback and symptoms, and generates exportable reports that can be shared with a dentist, doctor or physiotherapist. eu-startups.com

Trials and reimbursement

The app is registered as a Class I medical device under the EU MDR and complements dental care. The startup reported that clinical pilot projects are running at five sites, including University Hospital RWTH Aachen. eu-startups.com A multicentre randomised controlled trial with 130 patients is due to start in December 2026. eu-startups.com

JawBuddy is also negotiating a care contract with a major statutory health insurer, due to start in early 2027. eu-startups.com "With this funding, we are now starting the clinical trial and taking the next step towards reimbursement," said co-founder and CEO Leon Rauch. Luisa Wasilewski, Pool Captain at HALBZEIT, said the fund invests where a large, underserved market, a clear clinical need and a reimbursable model come together. eu-startups.com

Leipzig startup JawBuddy raises €818k pre-Seed to fund a clinical trial of its jaw pain app

How the app works

Trials and reimbursement

Sources · 1

Read also

Hardt Hyperloop raises multi-million-euro round led by Green Rock after March bankruptcy